<table id="id_b965281b-6e79-48f3-883d-dc3ec233deff" width="791.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_22dc6982-c1ec-4067-83e3-ced54fb29fa8">Table 1. Summary of Norethindrone (NE) and Ethinyl Estradiol (EE) Pharmacokinetic Parameter Values Following Oral Administration of Lo Loestrin Fe to Healthy Female Volunteers (n = 15)</caption>
<col width="21.5%"></col>
<col width="8.0%"></col>
<col width="7.1%"></col>
<col width="12.1%"></col>
<col width="13.1%"></col>
<col width="13.9%"></col>
<col width="12.5%"></col>
<col width="11.8%"></col>
<tbody>
<tr id="id_94f45862-41d5-4033-820f-f2e05dd6cd1f">
<td align="left" rowspan="2" stylecode="Botrule Toprule Rrule Lrule" valign="middle">Regimen</td>
<td align="center" rowspan="2" stylecode="Botrule Rrule" valign="middle">Study Day</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"></td>
<td align="center" colspan="5" stylecode="Botrule Rrule" valign="middle">Arithmetic Mean<footnote id="id-ba9129eb-b1c7-484e-a863-e3874c5b8369">The median (range) is reported for t<sub>max</sub>
</footnote> (Percent CV) by Pharmacokinetic Parameter</td>
</tr>
<tr id="id_f2b462b5-71db-43fe-8772-be195d6ae20c">
<td align="center" stylecode="Lrule Botrule Rrule" valign="middle">Analyte</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">C<sub>max</sub>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">t<sub>max</sub>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">AUC<sub>0-24h</sub>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">C<sub>min</sub>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">C<sub>avg</sub>
</td>
</tr>
<tr id="id_46dc563e-25f0-4e95-af44-4224e2770ac6">
<td align="left" rowspan="3" stylecode="Lrule Botrule Rrule" valign="middle">
<paragraph>Single Dose</paragraph>Lo Loestrin Fe combination tablet<footnote id="id-05ea2453-8fff-47ae-90dd-33b8b978f1db">Lo Loestrin Fe combination tablets contain 1 mg norethindrone acetate and 10 mcg ethinyl estradiol</footnote>
</td>
<td align="center" rowspan="3" stylecode="Botrule Rrule" valign="middle">1</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">NE</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">7360 (21)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">1.7 (1.3-6.0)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">33280 (33)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">--</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">--</td>
</tr>
<tr id="id_b2623fff-516e-47df-9f93-9ad3f72cac27">
<td align="center" stylecode="Lrule Botrule Rrule" valign="middle">EE</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">50.9 (27)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">1.3 (1.0-6.0)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">389.9 (27)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">--</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">--</td>
</tr>
<tr id="id_94316ed4-adaa-45b2-a31a-0f7c5f26c813">
<td align="center" stylecode="Lrule Botrule Rrule" valign="middle">SHBG</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">--</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">--</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">--</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">54.8 (33)<footnote id="id-26df4928-803f-46a7-a266-ba961bb0b687">The C<sub>min</sub> concentration reported for SHBG is the pre-dose concentration</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">--</td>
</tr>
<tr id="id_22c0d712-a02d-49dd-a31e-cb9b6c951e85">
<td align="left" rowspan="3" stylecode="Lrule Botrule Rrule" valign="middle">
<paragraph>Multiple Dose </paragraph>Lo Loestrin Fe combination tablet<footnoteref idref="id-05ea2453-8fff-47ae-90dd-33b8b978f1db"></footnoteref>
<br/>x 24 days </td>
<td align="center" rowspan="3" stylecode="Botrule Rrule" valign="middle">24</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">NE</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">13900 (34)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">1.3 (0.7–3.0)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">84160 (41)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">917 (84)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">3510 (41)</td>
</tr>
<tr id="id_b89e4ca5-fb98-452a-987e-68f230ac47a1">
<td align="center" stylecode="Lrule Botrule Rrule" valign="middle">EE</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">71.3 (33)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">1.3 (0.3–2.0)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">621.3 (41)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">10.0 (92)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">25.9 (41)</td>
</tr>
<tr id="id_b347ed14-c2cc-4d3e-87d4-6dfd0e20a933">
<td align="center" stylecode="Lrule Botrule Rrule" valign="middle">SHBG</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">--</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">--</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">--</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">109 (38)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">--</td>
</tr>
<tr id="id_89218bfb-1770-467a-b2c5-d1e2c1c9eaf1">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">
<paragraph>Multiple Dose </paragraph>
<paragraph>Lo Loestrin Fe combination tablet<footnoteref idref="id-05ea2453-8fff-47ae-90dd-33b8b978f1db"></footnoteref>
<br/>x 24 days and ethinyl estradiol alone tablet<footnote id="id-c62f4eab-326b-488b-a6bf-88f52f933cec">Lo Loestrin Fe ethinyl estradiol alone tablets contain 10 mcg ethinyl estradiol</footnote>
<br/>x 2 days</paragraph>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">26</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">EE</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">49.9 (34)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">1.3 (0.7–3.0)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">403.6 (50)</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">--</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">--</td>
</tr>
<tr id="id_54e22e44-0f52-43f2-afeb-dd14f9223833">
<td align="left" colspan="8" stylecode="Lrule Botrule Rrule" valign="middle">
<paragraph>C<sub>max</sub> = Maximum plasma concentration (pg/mL); t<sub>max</sub> = Time of C<sub>max</sub> (h); AUC<sub>0-24h</sub> = Area under plasma concentration versus time curve from 0 to 24 hours (pg·h/mL); C<sub>min</sub> = Minimum plasma concentration (pg/mL); C<sub>avg</sub> = Average plasma concentration = AUC<sub>0–24h</sub>/24 (pg/mL)</paragraph>Percent CV = Coefficient of Variation (percent); SHBG = Sex hormone binding globulin (nmol/L)</td>
</tr>
</tbody>
</table>